|
|
|
|
|
|
|
|
|
MSDS   | : | Nicotinamide, N-(3-(3-indolyl)propyl)-, hydrochloride
| CAS   | : | 72612-05-6 | SYNONYMS   | : | * N-(3-(3-Indolyl)propyl)nicotinamide hydrochloride
|
| |
|
|
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : QS4478000
CHEMICAL NAME : Nicotinamide, N-(3-(3-indolyl)propyl)-, hydrochloride
CAS REGISTRY NUMBER : 72612-05-6
LAST UPDATED : 198609
DATA ITEMS CITED : 1
MOLECULAR FORMULA : C17-H17-N3-O.Cl-H
MOLECULAR WEIGHT : 315.83
WISWESSER LINE NOTATION : T56 BMJ D3MV- CT6NJ &GH
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* N-(3-(3-Indolyl)propyl)nicotinamide hydrochloride
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 510 mg/kg
TOXIC EFFECTS :
Behavioral - anticonvulsant
Behavioral - changes in motor activity (specific assay)
Behavioral - analgesia
REFERENCE :
PJPPAA Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001,
00-068 Warsaw 1, Poland) V.25- 1973- Volume(issue)/page/year:
31,149,1979
*** END OF RECORD ***
|
|
|
|
|
|
|
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
Nitrosodisulfonic acid, dipotassium salt
| 14293-70-0 |
Nitrosporin
| 1400-54-0 |
Nitrous acid
| 7782-77-6 |
Nitrous acid, butyl ester
| 544-16-1 |
Nitrous acid, sec-butyl ester
| 924-43-6 |
Nitrous acid, t-butyl ester
| 540-80-7 |
Nitrous acid, isobutyl ester
| 542-56-3 |
Nitrous acid, ethyl ester
| 109-95-5 |
Nitrous acid, isopropyl ester
| 541-42-4 |
Nicotinamide, N-(3-(3-indolyl)propyl)-, hydrochloride
| 72612-05-6 |
Nitrous acid, methyl ester
| 624-91-9 |
Nitrous acid, nickel (2+) salt
| 17861-62-0 |
Nitrous acid, pentyl ester
| 463-04-7 |
Nitrous acid, propyl ester
| 543-67-9 |
Nitrous acid, sodium salt
| 7632-00-0 |
Nitroxide, di-tert-butyl
| 2406-25-9 |
NK 154183A
| 152986-47-5 |
NK 154183B
| 152986-49-7 |
NN-105
| 152986-49-7 |
Noboritomycin A
| 68508-45-2 |
Nicotinamide, N-isopentyl-2-(p-methylanilino)-
| 65423-31-6 |
Noboritomycin A, 4-demethyl-4-ethyl-
| 68508-46-3 |
Nocardicin complex
| 76631-42-0 |
Nocardin
| 101975-69-3 |
Nocardorubin
| 1404-14-4 |
NOF-005SUBSTANCE DEFINITION :Chief ingredient of tricaprylinREFERENCE :KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, KandaSuda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-Volume(issue)/page/year: 28,7,1994
| 1404-14-4 |
Nogalamycin
| 1404-15-5 |
Nomate blockaide
| 85800-68-6 |
Nonactin,5,14,23,32-tetrademethyl-5,14,23,32-tetraethyl-
| 33956-61-5 |
2,3-Nonadecanediamine, dihydrochloride, (+-)-
| 33956-61-5 |
1,2,3-Nonadecanetricarboxylic acid, 2-hydroxy-
| 666-99-9 |
Nicotinamide, 2-(p-methoxyanilino)-N-methyl-
| 65423-33-8 |
1,2,3-Nonadecanetricarboxylic acid, 2-hydroxy-,sodium salt
| 78219-78-0 |
10-Nonadecanone, 1,19-difluoro-
| 462-17-9 |
2,10,12,16,18-Nonadecapentanoic acid,19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl- 6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-
| 87081-35-4 |
2,10,12,16,18-Nonadecapentaenoic acid,19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-3,5,7,9,11,15,17-heptamethyl-6-hydroxy-8-oxo-
| 87081-36-5 |
5,9,13,17-Nonadecatetraen-2-one,6,10,14,18-tetramethyl-
| 6809-52-5 |
10-Nonadecenamide,N-((4-hydroxy-3-methoxyphenyl)methyl)-, (Z)-
| 95548-11-1 |
2,6-Nonadienal, (E,Z)-
| 557-48-2 |
2,6-Nonadien-1-al, 3,7-dimethyl-
| 41448-29-7 |
2,6-Nonadienenitrile, 3,7-dimethyl-
| 61792-11-8 |
2,6-Nonadienol
| 28069-72-9 |
Nicotinamide,1,4-dihydro-N,1-bis(p-chlorophenyl)-2,6-dimethyl-4-oxo-
| 80357-39-7 |
Nicotinamide, 2-(p-methoxyanilino)-N-propyl-
| 65423-35-0 |
1,6-Nonadien-3-ol, 3,7-dimethyl-
| 10339-55-6 |
1,6-Nonadien-3-ol, 3,7-dimethyl-, acetate
| 61931-80-4 |
5,7-Nonadiyn-4-one, 9-(2-naphthalenyloxy)-
| 52714-38-2 |
1,4-Nonadiyn-3-one, 1-phenyl-
| 50655-45-3 |
Nonaethylene glycol
| 3386-18-3 |
Nonamethylenediamine, N,N'-bis(o-chlorobenzyl)-,dihydrochloride
| 2056-23-7 |
|
|
|
|